Matador was delighted to work closely with Kyowa Kirin Corporation to introduce them to the capabilities of the Generis CARA™ Life Science Platform for their Global Regulatory Correspondence Management.

I am so proud how Matador in our role, as Generis' Japan sales team initially created the lead with KKC and then worked closely with the client and Generis to ensure that KKC's requirements were all met. This is a mission-critical application for any pharmaceutical company and we appreciate the trust that has been placed in our partnership.

John Bolger
CEO, Matador Japan
Commercial Director, Generis Japan

The full Generis and Kyowa Kirin Corporation press release can be found here.